CTLA-4, PD-1 and TIM-3 expression predominantly downregulated in MS patients

被引:28
|
作者
Mohammadzadeh, Adel [1 ]
Rad, Isa Abdi [2 ]
Ahmadi-Salmasi, Babak [3 ]
机构
[1] Urmia Univ Med Sci, Dept Immunol & Genet, Orumiyeh, Iran
[2] Urmia Univ Med Sci, Dept Genet, Orumiyeh, Iran
[3] Urmia Univ Med Sci, Dept Neurol, Imam Khomeini Hosp, Orumiyeh, Iran
关键词
CTLA-4; PD-1; TIM-3; Multiple sclerosis; T-CELL-ACTIVATION; MULTIPLE-SCLEROSIS; ASSOCIATION; MECHANISMS; GALECTIN-9; INFECTION; PROMOTES; DISEASE;
D O I
10.1016/j.jneuroim.2018.08.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple sclerosis (MS), is an autoimmune disorder of central nervous system (CNS) characterized by inflammation and demyelination. Self-tolerance impairment is considered to be induced by a combination of inherited susceptibility and environmental agents. In this work, we demonstrate that a reduction in the comparative expression of well-known inhibitory receptors (i.e., CTLA-4, PD-1, and TIM-3) is importantly linked with MS patients compared to healthy controls. The relative expression of interested genes was performed on peripheral blood mononuclear cells (PBMCs), by using quantitative real time-PCR (qRT-PCR). Our data high-lighted the role of inhibitory receptors in the maintenance of immune homeostasis in autoimmune disease.
引用
收藏
页码:105 / 108
页数:4
相关论文
共 50 条
  • [41] The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis
    Wu, Kongju
    Yi, Ming
    Qin, Shuang
    Chu, Qian
    Zheng, Xinhua
    Wu, Kongming
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (01)
  • [42] A study on the efficacy and Safety Evaluation of a novel PD-1/CTLA-4 bispecific antibody
    Song, Qi
    Jiang, Meiling
    Pan, Xinrong
    Zhou, Guanyue
    Zhang, Xiaomeng
    IMMUNOBIOLOGY, 2024, 229 (06)
  • [43] The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis
    Kongju Wu
    Ming Yi
    Shuang Qin
    Qian Chu
    Xinhua Zheng
    Kongming Wu
    Experimental Hematology & Oncology, 8
  • [44] Idiopathic CD4 T Cell Lymphocytopenia: A Case of Overexpression of PD-1/PDL-1 and CTLA-4
    Kumar, Gaurav
    Schmid-Antomarchi, Heidy
    Schmid-Alliana, Annie
    Ticchioni, Michel
    Roger, Pierre-Marie
    INFECTIOUS DISEASE REPORTS, 2021, 13 (01) : 72 - 81
  • [45] Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in β-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype
    Shokrgozar, Negin
    Karimi, Mehran
    Golmoghaddam, Hossein
    Rezaei, Narges
    Moayed, Vida
    Sharifzadeh, Sedigheh
    Arandi, Nargess
    ANNALS OF HEMATOLOGY, 2021, 100 (10) : 2463 - 2469
  • [46] Increased Risk of Thyroid Dysfunction by PD-1 and CTLA-4 Blockade in Patients Without Thyroid Autoantibodies at Baseline
    Iwama, Shintaro
    Kobayashi, Tomoko
    Yasuda, Yoshinori
    Okuji, Takayuki
    Ito, Masaaki
    Ando, Masahiko
    Zhou, Xin
    Yamagami, Ayana
    Onoue, Takeshi
    Kawaguchi, Yohei
    Miyata, Takashi
    Sugiyama, Mariko
    Takagi, Hiroshi
    Hagiwara, Daisuke
    Suga, Hidetaka
    Banno, Ryoichi
    Hase, Tetsunari
    Morise, Masahiro
    Wakahara, Keiko
    Yokota, Kenji
    Kato, Masashi
    Nishio, Naoki
    Tanaka, Chie
    Miyata, Kazushi
    Ogura, Atsushi
    Ito, Takanori
    Sawada, Tsunaki
    Shimokata, Tomoya
    Niimi, Kaoru
    Ohka, Fumiharu
    Ishigami, Masatoshi
    Gotoh, Momokazu
    Hashimoto, Naozumi
    Saito, Ryuta
    Kiyoi, Hitoshi
    Kajiyama, Hiroaki
    Ando, Yuichi
    Hibi, Hideharu
    Sone, Michihiko
    Akiyama, Masashi
    Kodera, Yasuhiro
    Arima, Hiroshi
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (04) : E1620 - E1630
  • [47] Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer
    Kuai, Wentao
    Xu, Xinjian
    Yan, Jing
    Zhao, Wujie
    Li, Yaxing
    Wang, Bin
    Yuan, Na
    Li, Zhongxin
    Jia, Yitao
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [48] CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms
    A Ligers
    N Teleshova
    T Masterman
    W-X Huang
    J Hillert
    Genes & Immunity, 2001, 2 : 145 - 152
  • [49] CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms
    Ligers, A
    Teleshova, N
    Masterman, T
    Huang, WX
    Hillert, J
    GENES AND IMMUNITY, 2001, 2 (03) : 145 - 152
  • [50] DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
    Nair, Varun Sasidharan
    El Salhat, Haytham
    Taha, Rowaida Z.
    John, Anne
    Ali, Bassam R.
    Elkord, Eyad
    CLINICAL EPIGENETICS, 2018, 10